Who invested in ATB Therapeutics?
ATB Therapeutics's investors include EQT Life Sciences.
Belgium · Series A startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$57Mraised across 1 round since 2024, from 1 source
ATB Therapeutics's investors include EQT Life Sciences.
ATB Therapeutics has raised $57M across 1 round since 2024.
ATB Therapeutics's most recent round was a Series A of $57M in Nov 2024.
Its most recent round, $57M in Nov 2024, is also its largest on record.
ATB Therapeutics's first round on record, in Nov 2024, was backed by EQT Life Sciences.
ATB Therapeutics's latest named round is a Series A, in Nov 2024.
ATB Therapeutics is based in Belgium.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.